Sensex tanks 984 pts, ends at 48,782; financials crack; Nifty Pharma up 1%

On a weekly basis, both the frontline indices snapped their 3-week losing streak and added around 2 per cent higher each

4:25 PM

TECH VIEW :: Nagaraj Shetti, Technical Research Analyst at HDFC Securities

The sharp weakness of Friday, after the failed upside breakout attempt of upper range at 15K of Thursday seems to have dampen the effort of bulls. The overall chart setup from smaller to larger time frame signal chances of upside bounce in the market from the lower levels and a formation of higher bottom around the support of 14500-14400 levels by next week. On the upside 14850 is likely to act as a hurdle.

 

4:20 PM

MARKET CLOSING COMMENT :: Vinod Nair, Head of Research at Geojit Financial Services

The market turned into a correction phase following weakness in the Asian market despite hopeful signs from Wall Street. Rising covid cases and uncertainties surrounding vaccination added more pressure on the market. Along with small-cap stocks, pharma, metal, and oil & gas were the sectoral gainers while profit booking was seen in banking stocks

4:17 PM

TECH VIEW :: Rohit Singre, Senior Technical Analyst at LKP Securities

Index opened a day with a gap down & traded whole day with negative bias and closed day at 14631 with loss of nearly two per cent forming a bearish candle on the daily chart.  On the downside index has good support at 14580-14500 zone if managed to save said levels then some bounce possible otherwise we may see the next leg of a move towards 14200 zone on the downside, resistance is placed at 14730-14810 zone we may see profit booking again around these levels

4:14 PM

Primary market action :: PowerGrid InviT IPO subscribed 54% so far on Day 2

4:07 PM

Ahead of results :: IndusInd Bank ends marginally lower

4:05 PM

Ahead of results :: Reliance Industries slips 1.4%

4:02 PM

Sector of the day :: Shriram Transport Fin, HDFC top laggards on the index

3:59 PM

Sector of the day :: Divi's Labs, Cadila Health top gainers on Nifty Pharma index

3:55 PM

Broader market :: S&P BSE SmallCap ends flat

3:52 PM

Broader market :: S&P BSE MidCap index slips in trade but outperform benchmarks

3:50 PM

Stocks that witnessed heavy volumes on the Sensex today

3:48 PM

Top drags on the Sensex today

3:44 PM

Sectoral trends on the NSE :: Financial index falls 3%, Pharma up 1%

3:41 PM

Sensex Heatmap at Close :: Only 5 of the 30 constituents end in the green

3:33 PM

CLOSING BELL

The benchmark indices eased 2 per cent today amid massive selling in all but pharma sector. The Nifty Bank and Financial Services indices took the sharpest knock and dropped 3 per cent each while the Nifty FMCG, Auto, IT, and Realty indices slipped up to 1.5 per cent. The Nifty Pharma index, which hit a record high of 13,619 in the intra-day trade, bucked the trend and gained settled 1 per cent higher.

 

In effect, NSE's 50-share index erased 264 points to close at 14,631 levels dragged mainly by HDFC (down 4.2 per cent), HDFC Bank (4 per cent), ICICI Bank, Kotak Mahindra Bank, Asian Paints,  M&M, TCS, Tata Motors, and Adani Ports. The losses were, however, capped by gains in ONGC (4 per cent), Coal India, Divi's Labs, Grasim, and Indian Oil Corporation.   

 

On the BSE, the Sensex index nursed losses in 27 of the 30 constituents and ended at 48,782 levels today, down 983 points.

 

3:25 PM

Only 3 stocks hold head above water as Sensex turns into a sea of red

3:22 PM

MARKET CHECK :: Nifty nears 14,600

3:10 PM

Bear crawl :: Sensex tumbles over 950 pts

3:06 PM

Euro zone GDP shrinks less than expected in Q1, April inflation rises

The euro zone economy shrank less than expected in the first three months of the year, preliminary data showed on Friday, while headline inflation picked up as expected on a surge in energy prices.
 

The European Union's statistics office Eurostat said gross domestic product in the 19 countries sharing the euro contracted 0.6% quarter-on-quarter for a 1.8% year-on-year fall. READ MORE

2:54 PM

Credit Suisse board member Gottschling to exit after Archegos debacle

Credit Suisse Group AG risk committee head Andreas Gottschling is stepping down from his role after prominent investors indicated they’ll vote to oust him following the $5.5 billion hit from the meltdown of Archegos Capital Management. Gottschling is standing down ahead of the bank’s annual general meeting on Friday, according to a statement from the company. Shareholder advisory firms including Glass Lewis had urged the bank’s investors to vote against re-electing him for another yearly term. READ MORE

2:42 PM

Ahead of results :: Reliance Industries slips 0.6%

2:26 PM

US won't release AstraZeneca's vaccine until sure about safety: Official

The US Food and Drug Administration will not release AstraZeneca's coronavirus vaccine for export to other countries until it is sure the doses have been manufactured to US quality standards and will be safe and effective, a government official told CNN on Thursday.

 

According to CNN, The White House said on Monday it would ship doses of AstraZeneca vaccine to other countries, including India, after a safety review by the FDA. READ MORE

2:25 PM

PowerGrid Infrastructure Investment Trust IPO subscribed 25% so far on Day 2

2:17 PM

Motherson Sumi Systems gets shareholders' nod for proposed restructuring

As part of the restructuring which was announced in July last year, after the demerger of DWH, group firm Samvardhana Motherson International Ltd (SAMIL) is to be merged into MSSL to consolidate 100 per cent shareholding in Samvardhana Motherson Automotive Systems Group BV (SMRP BV) as well as to bring all auto component and allied businesses in SAMIL under MSSL. READ MORE

2:05 PM

Sensex nears day's low, drops 800 points

1:57 PM

Top Sensex drags at this hour

1:55 PM

AstraZeneca reports Covid vaccine sales of $275 mn, expects hit to ease

AstraZeneca said its COVID-19 vaccine contributed $275 million to first-quarter sales and shaved three cents per share from its earnings, as it posted better-than-expected results and forecast growth in the second half.

 

This is the first time the Anglo-Swedish drugmaker has given financial details of the distribution and sales of its vaccine, which it developed with Oxford University. It has said it will not make a profit from the shot during the pandemic. READ MORE

1:42 PM

March Quarter Results :: Marico reports profit of Rs 227 crore, misses estimates

>> Revenue at Rs 2,012 crore

>> One-time loss of Rs 19 crore

>> Ebitda at Rs 319 crore

>> Ebitda margin at 15.9%

1:24 PM

Asset quality, second Covid wave concerns weigh on AU Small Finance Bank

Shares of AU Small Finance Bank plummeted 10 per cent to hit a low of Rs 1,013 on the BSE on Friday as the lender's asset quality worsened in the March quarter of FY21 (Q4FY21). In comparison, the benchmark S&P BSE Sensex was down 1 per cent at 1:12 PM. According to the financial statement of the bank, the gross non-performing assets (NPAs) spiked to 4.25 per cent of gross advances as of March 31, 2021, from 1.68 per cent in the same period last year. READ MORE

1:15 PM

Market Check :: Sensex declines 500 points